positionForPages[70]={page:70,positions:[{w:"60",p:[0.021502,0.039294,0.047607,0.039294,0.047607,0.019261,0.021502,0.019261,0.000000,0.000000]},{w:"TreaTmenT approaches",p:[0.097208,0.039084,0.362685,0.039084,0.362685,0.019649,0.097208,0.019649,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS ",p:[0.097141,0.974259,0.701335,0.974259,0.701335,0.960936,0.097141,0.960936,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.701335,0.974259,0.705081,0.974259,0.705081,0.960936,0.701335,0.960936,0.000000]},{w:"VOLUME 1",p:[0.705252,0.974259,0.786566,0.974259,0.786566,0.959690,0.705252,0.959690,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"until the ua level is below 0.4 mmol/l. Patients ",p:[0.096970,0.098182,0.479932,0.098182,0.479932,0.083193,0.096970,0.083193,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"intolerant to colchicine can be offered low-dose ",p:[0.096970,0.113991,0.479951,0.113991,0.479951,0.099002,0.096970,0.099002,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"nSaIds, unless contraindicated, to use should an ",p:[0.096970,0.129799,0.479951,0.129799,0.479951,0.114811,0.096970,0.114811,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"attack occur while initiating ult.",p:[0.096970,0.145608,0.343253,0.145608,0.343253,0.130620,0.096970,0.130620,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"12",p:[0.343250,0.139824,0.354199,0.139824,0.354199,0.131086,0.343250,0.131086,0.000000,0.000000]},{w:"Importantly, should an acute attack occur, ",p:[0.115151,0.161418,0.479987,0.161418,0.479987,0.146429,0.115151,0.146429,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"allopurinol  should not  be  stopped, but rather ",p:[0.096967,0.177226,0.479968,0.177226,0.479968,0.162238,0.096967,0.162238,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"continued alongside the treatment for the acute ",p:[0.096967,0.193035,0.479949,0.193035,0.479949,0.178047,0.096967,0.178047,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"attack. Patients and their healthcare providers ",p:[0.096967,0.208844,0.479987,0.208844,0.479987,0.193855,0.096967,0.193855,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"need to be educated about this principle, because ",p:[0.096967,0.224653,0.479949,0.224653,0.479949,0.209664,0.096967,0.209664,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"otherwise a vicious cycle of acute attack, initiation ",p:[0.096967,0.240462,0.479987,0.240462,0.479987,0.225473,0.096967,0.225473,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"of ult, new attack, discontinuation of ult, recurrent ",p:[0.096967,0.256271,0.479987,0.256271,0.479987,0.241282,0.096967,0.241282,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"attack ensues with little progress made to prevent ",p:[0.096986,0.272080,0.479949,0.272080,0.479949,0.257091,0.096986,0.257091,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"future attacks by lowering ua levels.  ",p:[0.096986,0.287888,0.373923,0.287888,0.373923,0.272900,0.096986,0.272900,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"the  dose of allopurinol  should be  titrated ",p:[0.115170,0.303697,0.479987,0.303697,0.479987,0.288709,0.115170,0.288709,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"upwards every two to five weeks.  recent data ",p:[0.096986,0.319506,0.479987,0.319506,0.479987,0.304517,0.096986,0.304517,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"have shown that allopurinol at a dose of ≤300 mg ",p:[0.096986,0.335315,0.480006,0.335315,0.480006,0.320326,0.096986,0.320326,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"daily fails to achieve an appropriate reduction in ",p:[0.096986,0.351124,0.479949,0.351124,0.479949,0.336135,0.096986,0.336135,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"serum ua levels in approximately 30-50% of gout ",p:[0.096986,0.366933,0.479930,0.366933,0.479930,0.351944,0.096986,0.351944,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"patients with normal renal function.  a treat-to-",p:[0.096986,0.382742,0.475756,0.382743,0.475756,0.367754,0.096986,0.367753,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"14",p:[0.378428,0.376958,0.389377,0.376958,0.389377,0.368220,0.378428,0.368220,0.000000,0.000000]},{w:"target strategy is suggested where allopurinol ",p:[0.096970,0.398552,0.479970,0.398552,0.479970,0.383563,0.096970,0.383563,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"is increased until a target serum  ua level of ",p:[0.096970,0.414360,0.479970,0.414360,0.479970,0.399372,0.096970,0.399372,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"0,36  mmol/l, or 0.30 in patients with tophi, is ",p:[0.096970,0.430169,0.479990,0.430169,0.479990,0.415181,0.096970,0.415181,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"reached. allopurinol can be prescribed in doses ",p:[0.096970,0.445978,0.480009,0.445978,0.480009,0.430989,0.096970,0.430989,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"up to 800 mg daily. ",p:[0.096970,0.461787,0.247811,0.461787,0.247811,0.446798,0.096970,0.446798,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Febuxostat is an alternative XoI with a much ",p:[0.115154,0.477596,0.479970,0.477596,0.479970,0.462607,0.115154,0.462607,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"lower risk of hypersensitivity reactions, but is ",p:[0.096970,0.493405,0.479951,0.493405,0.479951,0.478416,0.096970,0.478416,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"expensive, not yet available in South  africa ",p:[0.096970,0.509214,0.479970,0.509214,0.479970,0.494225,0.096970,0.494225,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"and may be associated with increased risk of ",p:[0.096970,0.525022,0.479990,0.525022,0.479990,0.510034,0.096970,0.510034,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"cardiovascular events. ",p:[0.096970,0.540831,0.268593,0.540831,0.268593,0.525843,0.096970,0.525843,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Uricosurics",p:[0.096970,0.573551,0.204402,0.573551,0.204402,0.553792,0.096970,0.553792,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Probenecid can be used in the management of ",p:[0.096970,0.588625,0.479970,0.588625,0.479970,0.573636,0.096970,0.573636,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"chronic gout, including combination therapy ",p:[0.096970,0.604434,0.479990,0.604434,0.479990,0.589445,0.096970,0.589445,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"with XoI. It is contraindicated in patients with ",p:[0.096970,0.620243,0.479970,0.620243,0.479970,0.605254,0.096970,0.605254,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"a history of urolithiasis, patients who produce ",p:[0.096970,0.636051,0.479970,0.636051,0.479970,0.621063,0.096970,0.621063,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"excess ua and those who have renal failure with ",p:[0.096970,0.651860,0.479913,0.651860,0.479913,0.636872,0.096970,0.636872,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"an eGFr <50 ml/min.  Pegloticase is a pegylated ",p:[0.096970,0.667669,0.479981,0.667670,0.479981,0.652681,0.096970,0.652680,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"13,5",p:[0.257733,0.661885,0.276108,0.661885,0.276108,0.653147,0.257733,0.653147,0.000000,0.000000,0.000000,0.000000]},{w:"uricase employed in the management of severe ",p:[0.096961,0.683479,0.479943,0.683479,0.479943,0.668490,0.096961,0.668490,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"refractory gout and can be used in patients with ",p:[0.096961,0.699287,0.479904,0.699287,0.479904,0.684299,0.096961,0.684299,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"renal impairment. Its use is limited due to its cost.",p:[0.096961,0.715096,0.474054,0.715096,0.474054,0.700108,0.096961,0.700108,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"concomitant medication",p:[0.096970,0.747815,0.348500,0.747815,0.348500,0.728057,0.096970,0.728057,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Where possible, drugs that cause hyperuricaemia ",p:[0.096970,0.762889,0.479932,0.762889,0.479932,0.747900,0.096970,0.747900,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"should be reviewed and discontinued. However, ",p:[0.096970,0.778698,0.479932,0.778698,0.479932,0.763709,0.096970,0.763709,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"low-dose aspirin for cardio-protection should not ",p:[0.096970,0.794507,0.480009,0.794507,0.480009,0.779518,0.096970,0.779518,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"be stopped; diuretics may be difficult to withdraw ",p:[0.096970,0.810316,0.479970,0.810316,0.479970,0.795327,0.096970,0.795327,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"in heart failure or renal insufficiency and should ",p:[0.096970,0.826125,0.479970,0.826125,0.479970,0.811136,0.096970,0.811136,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"be prescribed continuously at the lowest dose ",p:[0.096970,0.841933,0.479951,0.841933,0.479951,0.826945,0.096970,0.826945,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"possible, because intermittent use of diuretics can ",p:[0.096970,0.857742,0.479951,0.857742,0.479951,0.842754,0.096970,0.842754,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"precipitate gout flares. drugs with mild uricosuric ",p:[0.096970,0.873551,0.479951,0.873551,0.479951,0.858562,0.096970,0.858562,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"action  include losartan (angiotensin receptor ",p:[0.096970,0.889360,0.479990,0.889360,0.479990,0.874371,0.096970,0.874371,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"blocker), amlodipine (calcium-channel blocker), ",p:[0.096970,0.905169,0.479990,0.905169,0.479990,0.890180,0.096970,0.890180,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"statins and fenofibrates, and should be prescribed ",p:[0.096970,0.920978,0.479932,0.920978,0.479932,0.905989,0.096970,0.905989,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"where possible. ",p:[0.096970,0.936641,0.220159,0.936641,0.220159,0.921652,0.096970,0.921652,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"AsympTomATic hyperuricAemiA",p:[0.524477,0.099502,0.891201,0.099502,0.891201,0.079744,0.524477,0.079744,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"the management  of asymptomatic hyper-",p:[0.524242,0.114055,0.903048,0.114055,0.903048,0.099066,0.524242,0.099066,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"uricaemia is controversial. Currently,  ult is not ",p:[0.524242,0.129348,0.907204,0.129348,0.907204,0.114359,0.524242,0.114359,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"advised for its management. However there ",p:[0.524242,0.144641,0.907262,0.144641,0.907262,0.129652,0.524242,0.129652,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"may be advantages in treating asymptomatic ",p:[0.524242,0.159934,0.907223,0.159934,0.907223,0.144945,0.524242,0.144945,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"hyperuricaemia in patients with chronic kidney ",p:[0.524242,0.175226,0.907281,0.175226,0.907281,0.160238,0.524242,0.160238,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"disease and in the setting of patients post acute ",p:[0.524242,0.190519,0.907281,0.190519,0.907281,0.175531,0.524242,0.175531,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"myocardial infarction. Further studies are needed ",p:[0.524242,0.205812,0.907243,0.205812,0.907243,0.190824,0.524242,0.190824,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"to form future management guidelines.",p:[0.524242,0.221105,0.827213,0.221105,0.827213,0.206117,0.524242,0.206117,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"14,8",p:[0.827208,0.215282,0.845584,0.215282,0.845584,0.206544,0.827208,0.206544,0.000000,0.000000,0.000000,0.000000]},{w:"goAl of gouT TherApy",p:[0.524477,0.253264,0.787931,0.253264,0.787931,0.233505,0.524477,0.233505,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"the goal for all patients with gout is to achieve ",p:[0.524242,0.267816,0.907166,0.267816,0.907166,0.252827,0.524242,0.252827,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"a serum  ua level of 0.36 mmol/l,  with a  lower ",p:[0.524242,0.283109,0.907262,0.283109,0.907262,0.268120,0.524242,0.268120,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"goal (0.30 mmol/l) for patients with severe/",p:[0.524242,0.298402,0.903048,0.298402,0.903048,0.283413,0.524242,0.283413,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"tophaceous gout.  Patients can be reassured that ",p:[0.524242,0.313695,0.907258,0.313678,0.907258,0.298690,0.524242,0.298706,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"10",p:[0.659723,0.307894,0.670672,0.307894,0.670672,0.299155,0.659723,0.299155,0.000000,0.000000]},{w:"it is possible for attacks to stop and for tophi to ",p:[0.524238,0.328971,0.907142,0.328971,0.907142,0.313982,0.524238,0.313982,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"resolve with effective treatment.",p:[0.524238,0.344264,0.770829,0.344264,0.770829,0.329275,0.524238,0.329275,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"REfEREncEs",p:[0.524430,0.374837,0.637075,0.374837,0.637075,0.358446,0.524430,0.358446,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"1.   ragab G,  elshahaly M,  bardin  t. Gout:  an old ",p:[0.524242,0.388425,0.906798,0.388425,0.906798,0.375102,0.524242,0.375102,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"disease in new perspective – a review. ",p:[0.554551,0.402395,0.834173,0.402395,0.834173,0.389072,0.554551,0.389072,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"J Adv Res.",p:[0.837063,0.402395,0.903035,0.402395,0.903035,0.389307,0.837063,0.389307,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.903035,0.402395,0.906781,0.402395,0.906781,0.389072,0.903035,0.389072,0.000000]},{w:"2017;8(5):495-511.",p:[0.554551,0.416365,0.677805,0.416365,0.677805,0.403042,0.554551,0.403042,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"2.   dalbeth  n, Merriman tr, Stamp  lK. Gout. ",p:[0.524242,0.430335,0.853381,0.430335,0.853381,0.417012,0.524242,0.417012,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Lancet. ",p:[0.856289,0.430335,0.906097,0.430335,0.906097,0.417247,0.856289,0.417247,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"2016;388(10055):2039-52.2. ",p:[0.554551,0.444305,0.742955,0.444305,0.742955,0.430982,0.554551,0.430982,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"3.   Mandal aK, Mount db. the molecular physiology of ",p:[0.524242,0.458275,0.906747,0.458275,0.906747,0.444952,0.524242,0.444952,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"uric acid homeostasis. ",p:[0.554534,0.472245,0.700194,0.472245,0.700194,0.458922,0.554534,0.458922,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Ann Rev Physiol. ",p:[0.699852,0.472245,0.801521,0.472245,0.801521,0.459157,0.699852,0.459157,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"2015;77:323-45.",p:[0.801178,0.472245,0.902231,0.472245,0.902231,0.458922,0.801178,0.458922,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"4.   beyl  rn Jr, Hughes  l, Morgan S.  update ",p:[0.524225,0.486215,0.906781,0.486215,0.906781,0.472892,0.524225,0.472892,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"on  importance  of  diet  in  gout. ",p:[0.554534,0.500185,0.811287,0.500185,0.811287,0.486862,0.554534,0.486862,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Am J Med.",p:[0.820883,0.500185,0.903018,0.500185,0.903018,0.487097,0.820883,0.487097,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.903018,0.500185,0.906764,0.500185,0.906764,0.486862,0.903018,0.486862,0.000000]},{w:"2016;129(11):1153-8.",p:[0.554534,0.514155,0.694481,0.514155,0.694481,0.500832,0.554534,0.500832,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"5.   Klippel  J, ",p:[0.524225,0.528125,0.621822,0.528125,0.621822,0.514802,0.524225,0.514802,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et  al.  Primer  on  the  Rheumatic  Diseases. ",p:[0.626201,0.528125,0.906045,0.528125,0.906045,0.515037,0.626201,0.515037,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"berlin: Springer Science \& business Media; 2001.",p:[0.554534,0.542095,0.878080,0.542095,0.878080,0.528772,0.554534,0.528772,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"6.   neogi t, ",p:[0.524225,0.556065,0.614980,0.556065,0.614980,0.542742,0.524225,0.542742,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.617443,0.556065,0.649685,0.556065,0.649685,0.542977,0.617443,0.542977,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2015 Gout classification criteria: an ",p:[0.649685,0.556065,0.906747,0.556065,0.906747,0.542742,0.649685,0.542742,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"american College of  rheumatology/european ",p:[0.554534,0.570035,0.906764,0.570035,0.906764,0.556712,0.554534,0.556712,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"league against rheumatism collaborative initiative",p:[0.554534,0.584005,0.899392,0.584005,0.899392,0.570682,0.554534,0.570682,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:". ",p:[0.899392,0.584005,0.906114,0.584005,0.906114,0.569858,0.899392,0.569858,0.000000,0.000000]},{w:"Ann Rheum Dis.",p:[0.554517,0.597975,0.657639,0.597975,0.657639,0.584887,0.554517,0.584887,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2015;74(10):1789-98.",p:[0.657639,0.597975,0.801332,0.597975,0.801332,0.584652,0.657639,0.584652,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"7.   abrahams Mn. Gout and hyperuricaemia. ",p:[0.524208,0.611945,0.859333,0.611945,0.859333,0.598622,0.524208,0.598622,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"South ",p:[0.864259,0.611945,0.906062,0.611945,0.906062,0.598857,0.864259,0.598857,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"African Medical Journal.",p:[0.554517,0.625915,0.709858,0.625915,0.709858,0.612827,0.554517,0.612827,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2015;105(12).",p:[0.709858,0.625915,0.803744,0.625915,0.803744,0.612592,0.709858,0.612592,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"8.   Krishnan e, ",p:[0.524208,0.639885,0.631965,0.639885,0.631965,0.626562,0.524208,0.626562,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.631828,0.639885,0.661932,0.639885,0.661932,0.626797,0.631828,0.626797,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Hyperuricemia and untreated gout ",p:[0.661932,0.639885,0.906729,0.639885,0.906729,0.626562,0.661932,0.626562,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"are poor prognostic markers among those with a ",p:[0.554517,0.653855,0.906695,0.653855,0.906695,0.640532,0.554517,0.640532,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"recent acute myocardial infarction. ",p:[0.554517,0.667825,0.793310,0.667825,0.793310,0.654502,0.554517,0.654502,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Arthritis Res Ther.",p:[0.793208,0.667825,0.903035,0.667825,0.903035,0.654737,0.793208,0.654737,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.903035,0.667825,0.906781,0.667825,0.906781,0.654502,0.903035,0.654502,0.000000]},{w:"2012;14(1)r10.",p:[0.554517,0.681795,0.653294,0.681795,0.653294,0.668472,0.554517,0.668472,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"9.   van echteld I, ",p:[0.524208,0.695906,0.643647,0.695906,0.643647,0.682583,0.524208,0.682583,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.642211,0.695906,0.670535,0.695906,0.670535,0.682818,0.642211,0.682818,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Colchicine for acute gout. ",p:[0.670364,0.695906,0.842828,0.695906,0.842828,0.682583,0.670364,0.682583,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Cochrane ",p:[0.841408,0.695906,0.906080,0.695906,0.906080,0.682818,0.841408,0.682818,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Database Syst Rev.",p:[0.554517,0.710017,0.671921,0.710017,0.671921,0.696929,0.554517,0.696929,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2014 august;(8)Cd006190.",p:[0.671750,0.710017,0.851756,0.710017,0.851756,0.696694,0.671750,0.696694,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"10.   richette  P, ",p:[0.524225,0.724281,0.631247,0.724281,0.631247,0.710958,0.524225,0.710958,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.635010,0.724281,0.668329,0.724281,0.668329,0.711193,0.635010,0.711193,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2016 updated  eular evidence-",p:[0.668329,0.724281,0.903018,0.724281,0.903018,0.710958,0.668329,0.710958,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"based recommendations for the management of ",p:[0.554534,0.738545,0.906781,0.738545,0.906781,0.725222,0.554534,0.725222,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"gout. ",p:[0.554534,0.752809,0.594028,0.752809,0.594028,0.739486,0.554534,0.739486,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Ann Rheum Dis.",p:[0.594028,0.752809,0.697150,0.752809,0.697150,0.739721,0.594028,0.739721,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2017;76(1):29-42.",p:[0.697150,0.752809,0.815803,0.752809,0.815803,0.739486,0.697150,0.739486,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"11.   Hill eM, Sky K, Sit M, ",p:[0.524225,0.766920,0.696141,0.766920,0.696141,0.753597,0.524225,0.753597,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.697184,0.766920,0.728245,0.766920,0.728245,0.753832,0.697184,0.753832,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" does starting allopurinol ",p:[0.728245,0.766920,0.906729,0.766920,0.906729,0.753597,0.728245,0.753597,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"prolong acute treated gout? a randomized clinical ",p:[0.554517,0.781031,0.906747,0.781031,0.906747,0.767708,0.554517,0.767708,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"trial",p:[0.554517,0.795142,0.579934,0.795142,0.579934,0.781819,0.554517,0.781819,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:". ",p:[0.579934,0.795142,0.586656,0.795142,0.586656,0.780996,0.579934,0.780996,0.000000,0.000000]},{w:"J Clin Rheumatol.",p:[0.586656,0.795142,0.698980,0.795142,0.698980,0.782054,0.586656,0.782054,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2015;21:120-5.",p:[0.698980,0.795142,0.800221,0.795142,0.800221,0.781819,0.698980,0.781819,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"12.   nuki G, doherty M, richette P. Current management ",p:[0.524208,0.809253,0.906729,0.809253,0.906729,0.795930,0.524208,0.795930,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"of gout: Practical messages from 2016  eular ",p:[0.554499,0.823364,0.906729,0.823364,0.906729,0.810041,0.554499,0.810041,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"guidelines. ",p:[0.554499,0.837476,0.629759,0.837476,0.629759,0.824152,0.554499,0.824152,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Polish Arch Intern Med. ",p:[0.629280,0.837476,0.774872,0.837476,0.774872,0.824388,0.629280,0.824388,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"2017;127(4):267-77.",p:[0.774444,0.837476,0.902967,0.837476,0.902967,0.824152,0.774444,0.824152,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"13.   Khanna  d, ",p:[0.524190,0.851587,0.635933,0.851587,0.635933,0.838263,0.524190,0.838263,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.647273,0.851587,0.685382,0.851587,0.685382,0.838499,0.647273,0.838499,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"  2012  american College  of ",p:[0.685040,0.851587,0.906729,0.851587,0.906729,0.838263,0.685040,0.838263,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"rheumatology",p:[0.554499,0.865698,0.651361,0.865698,0.651361,0.852375,0.554499,0.852375,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"guidelines",p:[0.677069,0.865698,0.744255,0.865698,0.744255,0.852375,0.677069,0.852375,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"for",p:[0.769963,0.865698,0.787307,0.865698,0.787307,0.852375,0.769963,0.852375,0.000000,0.000000,0.000000]},{w:"management",p:[0.813015,0.865698,0.903001,0.865698,0.903001,0.852375,0.813015,0.852375,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"of gout. Part 1: Systematic nonpharmacologic ",p:[0.554499,0.879809,0.906712,0.879809,0.906712,0.866486,0.554499,0.866486,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"and pharmacologic therapeutic approaches to ",p:[0.554499,0.893920,0.906729,0.893920,0.906729,0.880597,0.554499,0.880597,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"hyperuricemia. ",p:[0.554499,0.908031,0.654834,0.908031,0.654834,0.894708,0.554499,0.894708,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Arthritis Care Res.",p:[0.654491,0.908031,0.759957,0.908031,0.759957,0.894943,0.654491,0.894943,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2012;64(10):1431-46.",p:[0.759615,0.908031,0.896467,0.908031,0.896467,0.894708,0.759615,0.894708,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"14.   Jalal dI, ",p:[0.524190,0.922142,0.608498,0.922142,0.608498,0.908819,0.524190,0.908819,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.608669,0.922142,0.639029,0.922142,0.639029,0.909054,0.608669,0.909054,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" uric acid as a target of therapy in CKd. ",p:[0.639029,0.922142,0.906729,0.922142,0.906729,0.908819,0.639029,0.908819,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Am J Kidney Dis.",p:[0.554499,0.936406,0.659212,0.936406,0.659212,0.923318,0.554499,0.923318,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2013;61(1):134-46.",p:[0.659212,0.936406,0.786212,0.936406,0.786212,0.923083,0.659212,0.923083,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]}]};